Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
TEM RXRX - Tempus and Recursion Extend Existing Data License Agreement and Enter New License Agreement for Recursion’s RNA Foundation Model
Tempus AI and Recursion Pharmaceuticals have extended their multi-year data partnership through November 2029 and entered a new agreement where Tempus will license Recursion's RNA Foundation Model.